Home NDC 64679-314 Clopidogrel
Product NDC 64679-314
11-digit product format 646790314
Labeler code 64679
Product ID 64679-314_a7370f50-bd1e-4ce4-8cd0-4ba6c0d6bfe4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Clopidogrel
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Wockhardt USA LLC.
Application ANDA202266
Marketing category ANDA
Marketing start 2012-08-14
Marketing end 0000-00-00
Substance CLOPIDOGREL BISULFATE
Active strength 75 mg/1
Pharmacologic classes Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2019-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 105 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 64679-314-02 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 64679-314-03 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 64679-314-04 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 64679-314-01 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 64679-314-02 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 64679-314-03 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 64679-314-04 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 64679-314-01 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 64679-314-02 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 64679-314-03 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 64679-314-04 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 64679-314-01 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 64679-314-02 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 64679-314-03 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 64679-314-04 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 64679-314-01 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 64679-314-02 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 64679-314-03 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 64679-314-04 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 64679-314-01 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 64679-314-02 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 64679-314-03 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 64679-314-04 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 64679-314-01 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 64679-314-02 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 64679-314-03 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 64679-314-04 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 64679-314-01 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 64679-314-02 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 64679-314-03 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 64679-314-04 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 64679-314-01 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 64679-314-02 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 64679-314-03 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 64679-314-04 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 64679-314-01 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 64679-314-03 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 64679-314-02 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 64679-314-01 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 64679-314-04 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 64679-314-03 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 64679-314-02 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 64679-314-01 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 64679-314-04 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 64679-314-03 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 64679-314-02 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 64679-314-01 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 64679-314-04 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202266-001 CLOPIDOGREL BISULFATE CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 A202266-002 CLOPIDOGREL BISULFATE CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2012-08-14 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL AB 2012-11-20 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A202266-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL 2012-08-14 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A202266-002 CLOPIDOGREL BISULFATE EQ 300MG BASE TABLET / ORAL 2012-11-20 782e0a99824c…
Observed Orange Book normalized TE history# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 64679-314-01 2024-11-14 These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 64679-314-02 2024-11-14 These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 64679-314-03 2024-11-14 These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 64679-314-04 2024-11-14 These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 64679-314-01 2020-01-31 These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 64679-314-02 2020-01-31 These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 64679-314-03 2020-01-31 These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 64679-314-04 2020-01-31 These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CLOPIDOGREL BISULFATE ACTIVE INGREDIENT 08I79HTP27 CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4 CLOPIDOGREL ACTIVE MOIETY A74586SNO7 CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4 GLYCERYL DIBEHENATE INACTIVE INGREDIENT R8WTH25YS2 CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4 HYDROGENATED CASTOR OIL INACTIVE INGREDIENT ZF94AP8MEY CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4 HYDROXYPROPYL CELLULOSE INACTIVE INGREDIENT RFW2ET671P CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4 HYPROMELLOSE 2910 (15 MPA.S) INACTIVE INGREDIENT 36SFW2JZ0W CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4 MANNITOL INACTIVE INGREDIENT 3OWL53L36A CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4 POLYETHYLENE GLYCOL 6000 INACTIVE INGREDIENT 30IQX730WE CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 CLOPIDOGREL TABLET, FILM COATED [WOCKHARDT USA LLC.] 4